vs
Side-by-side financial comparison of High-Trend International Group (HTCO) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
High-Trend International Group is the larger business by last-quarter revenue ($99.4M vs $70.6M, roughly 1.4× Viridian Therapeutics, Inc.\DE). High-Trend International Group runs the higher net margin — -13.4% vs -49.0%, a 35.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 185.2%). High-Trend International Group produced more free cash flow last quarter ($6.5M vs $-84.7M).
Motor Trend Group, LLC is a media company that specializes in enthusiast brands, such as Motor Trend and Hot Rod. Headquartered in El Segundo, California, it was a subsidiary of the TNT Sports division of Warner Bros. Discovery (WBD) until being sold to Hearst Communications in 2024.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
HTCO vs VRDN — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $99.4M | $70.6M |
| Net Profit | $-13.3M | $-34.6M |
| Gross Margin | 4.0% | — |
| Operating Margin | -12.5% | -56.7% |
| Net Margin | -13.4% | -49.0% |
| Revenue YoY | 185.2% | 81958.1% |
| Net Profit YoY | -1624.0% | 54.9% |
| EPS (diluted) | $-3.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $70.6M | ||
| Q2 25 | $99.4M | — | ||
| Q2 24 | $34.9M | — |
| Q3 25 | — | $-34.6M | ||
| Q2 25 | $-13.3M | — | ||
| Q2 24 | $-771.7K | — |
| Q3 25 | — | — | ||
| Q2 25 | 4.0% | — | ||
| Q2 24 | 7.0% | — |
| Q3 25 | — | -56.7% | ||
| Q2 25 | -12.5% | — | ||
| Q2 24 | 0.4% | — |
| Q3 25 | — | -49.0% | ||
| Q2 25 | -13.4% | — | ||
| Q2 24 | -2.2% | — |
| Q3 25 | — | — | ||
| Q2 25 | $-3.29 | — | ||
| Q2 24 | $-0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.2M | $490.9M |
| Total DebtLower is stronger | $1.0M | — |
| Stockholders' EquityBook value | $21.2M | $503.0M |
| Total Assets | $41.7M | $577.1M |
| Debt / EquityLower = less leverage | 0.05× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q2 25 | $13.2M | — | ||
| Q2 24 | $3.4M | — |
| Q3 25 | — | — | ||
| Q2 25 | $1.0M | — | ||
| Q2 24 | $2.0M | — |
| Q3 25 | — | $503.0M | ||
| Q2 25 | $21.2M | — | ||
| Q2 24 | $-5.3M | — |
| Q3 25 | — | $577.1M | ||
| Q2 25 | $41.7M | — | ||
| Q2 24 | $13.4M | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.05× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.5M | $-84.6M |
| Free Cash FlowOCF − Capex | $6.5M | $-84.7M |
| FCF MarginFCF / Revenue | 6.6% | -120.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-84.6M | ||
| Q2 25 | $6.5M | — | ||
| Q2 24 | $-3.5M | — |
| Q3 25 | — | $-84.7M | ||
| Q2 25 | $6.5M | — | ||
| Q2 24 | — | — |
| Q3 25 | — | -120.1% | ||
| Q2 25 | 6.6% | — | ||
| Q2 24 | — | — |
| Q3 25 | — | 0.2% | ||
| Q2 25 | 0.0% | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
